The objective of this study is to examine serum concentrations of hepcidin, suPar, and IL-6 as potential biomarkers for the non-invasive diagnosis of endometriosis, as well as their correlation with disease severity, as determined by the revised American Society for Reproductive Medicine (rASRM) score. The gene discussed is IL6; the disease is endometriosis.